News Headlines Article

Drugmakers relieved FDA has determined this year’s flu vaccine formula
Modern Healthcare

A federal advisory panel has chosen the influenza virus strains to be used in vaccine production for the 2016-17 flu season, alleviating some concerns about a possible supply shortage because of potential manufacturing delays.The U.S. Food and Drug Administration’s advisory committee recommended the California variant for the H1N1 and Hong Kong variations of the H3N2 strains of the influenza virus. It chose the Brisbane variation of influenza B to comprise the strains for the trivalent vaccine, and recommended adding the Phuket variant of the influenza B strain for the quadrivalent vaccine.